Phase III trial of Parkinson's disease gene therapy.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2011
At a glance
- Drugs AXO Lenti PD (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Oxford BioMedica
- 04 Aug 2011 Trial has not yet been initiated.
- 13 Mar 2008 New trial record.